While longitudinal studies have investigated the relationships between mild cognitive impairment (MCI) subtypes and dementia subtypes, the results have been contradictory. In addition, some research shows that depression accompanied by MCI might increase the risk of Alzheimer’s disease (AD).
Objective:
The aim of this study is to longitudinally investigate the relationships between MCI subtypes and dementia subtypes, with special attention to the effect of comorbid depressive symptoms in a Japanese rural community.
Methods:
Non-demented participants (n = 802) completed a baseline and follow-up study. Outcomes were conversion to dementia especially AD, MCI, or no conversion. A complementary log-log analysis was conducted to investigate the risk of dementia and AD in amnestic MCI (aMCI) compared to nonamnestic MCI (naMCI) groups. The impact of depressive symptoms on the transition from MCI to AD and from cognitively normal to MCI or AD was also analyzed.
Results:
The risk of developing dementia, in particular AD, for the aMCI group was significantly higher than that for the naMCI group. In the aMCI group, the presence of depressive symptoms increased the risk of developing AD, but depressive symptoms in the naMCI group did not. In the cognitively normal group, the presence of depressive symptoms increased the risk of aMCI but not naMCI or AD.
Conclusion:
MCI subtyping could be useful in finding a prodrome for dementia and in particular for AD. The differing impacts of depressive symptoms on the development of AD suggest that the relationship between depressive symptoms and cognitive impairment could differ in aMCI and naMCI patients.
PetersenRC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med256, 183–194.
3.
RasquinSM, LodderJ, VisserPJ, LousbergR, VerheyFR (2005) Predictive accuracy of MCI subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment: A 2-year follow-up study. Dement Geriatr Cogn Disord19, 113–119.
4.
YaffeK, PetersenRC, LindquistK, KramerJ, MillerB (2006) Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord22, 312–319.
5.
BusseA, HenselA, GuhneU, AngermeyerMC, Riedel-HellerSG (2006) Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology67, 2176–2185.
6.
FischerP, JungwirthS, ZehetmayerS, WeissgramS, HoenigschnablS, GelpiE, KramplaW, TraglKH (2007) Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology68, 288–291.
7.
ManlyJJ, TangMX, SchupfN, SternY, VonsattelJP, MayeuxR (2008) Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol63, 494–506.
8.
JungwirthS, ZehetmayerS, HinterbergerM, TraglKH, FischerP (2012) The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer’s dementia and vascular dementia. Int Psychogeriatr24, 959–966.
9.
HueyED, ManlyJJ, TangMX, SchupfN, BrickmanAM, ManoochehriM, MezJ, DeCarliC, DevanandDP, MayeuxR (2013) Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement9, 632–639.
10.
ModregoPJ, FerrandezJ (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study. Arch Neurol61, 1290–1293.
11.
GabryelewiczT, StyczynskaM, LuczywekE, BarczakA, PfefferA, AndrosiukW, Chodakowska-ZebrowskaM, WasiakB, PeplonskaB, BarcikowskaM (2007) The rate of conversion of mild cognitive impairment to dementia: Predictive role of depression. Int J Geriatr Psychiatry22, 563–567.
12.
StepaniukJ, RitchieLJ, TuokkoH (2008) Neuropsychiatric impairments as predictors of mild cognitive impairment, dementia, and Alzheimer’s disease. Am J Alzheimers Dis Other Demen23, 326–333.
13.
SteffensDC, McQuoidDR, PotterGG (2014) Amnestic mild cognitive impairment and incident dementia and Alzheimer’s disease in geriatric depression. Int Psychogeriatr26, 2029–2036.
14.
MiyamotoM, KodamaC, KinoshitaT, YamashitaF, HidakaS, MizukamiK, KakumaT, AsadaT (2009) Dementia and mild cognitive impairment among non-responders to a community survey. J Clin Neurosci16, 270–276.
15.
HidakaS, IkejimaC, KodamaC, NoseM, YamashitaF, SasakiM, KinoshitaT, TanimukaiS, MizukamiK, TakahashiH, KakumaT, TanakaS, AsadaT (2012) Prevalence of depression and depressive symptoms among older Japanese people: Comorbidity of mild cognitive impairment and depression. Int J Geriatr Psychiatry27, 271–279.
16.
YasunoF, TanimukaiS, SasakiM, HidakaS, IkejimaC, YamashitaF, KodamaC, MizukamiK, MichikawaM, AsadaT (2012) Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype. Am J Geriatr Psychiatry20, 574–583.
17.
YasunoF, TanimukaiS, SasakiM, IkejimaC, YamashitaF, KodamaC, HidakaS, MizukamiK, AsadaT (2012) Effect of plasma lipids, hypertension and APOE genotype on cognitive decline. Neurobiol Aging33, 2633–2640.
18.
NoseM, KodamaC, IkejimaC, MizukamiK, MatsuzakiA, TanakaS, YoshimuraA, YasunoF, AsadaT (2013) ApoE4 is not associated with depression when mild cognitive impairment is considered. Int J Geriatr Psychiatry28, 155–163.
19.
BunS, IkejimaC, KidaJ, YoshimuraA, LebowitzAJ, KakumaT, AsadaT (2015) A combination of supplements may reduce the risk of Alzheimer’s disease in elderly Japanese with normal cognition. J Alzheimers Dis45, 15–25.
20.
RitchieK, FuhrerR (1992) A comparative study of the performance of screening tests for senile dementia using receiver operating characteristics analysis. J Clin Epidemiol45, 627–637.
21.
NishimuraT, KobayashiT, HariguchiS, TakedaM, FukunagaT, InoueO, KondoH, NiigawaH, TanakaS, YamashitaM (1993) Scales for mental state and daily living activities for the elderly: Clinical behavioral scales for assessing demented patients. Int Psychogeriatr5, 117–134.
22.
SohlbergM, MateerCA (1986) Attention Process Training, Association for Neuropsychological Research and Development, Puyallup, WA.
23.
GroberE, BuschkeH, CrystalH, BangS, DresnerR (1988) Screening for dementia by memory testing. Neurology38, 900–903.
24.
FreedmanM, LeachL, KaplanE, WinocurG, ShulmanKI, DelisDC (1994) Clock Drawing: A Neuropsychological Analysis,
Oxford University Press, New York.
25.
SolomonPR, PendleburyWW (1998) Recognition of Alzheimer’s disease: The 7 Minute Screen. Fam Med30, 265–271.
26.
WechslerD (1981) WAIS-R: Manual: Wechsler Adult Intelligence Scale-Revised, Harcourt Brace Jovanovich for Psychological Corp, New York.
27.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
28.
SheikhJI, YesavageJA (1986) Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol5, 165–173.
29.
SteenlandK, KarnesC, SealsR, CarnevaleC, HermidaA, LeveyA (2012) Late-life depression as a risk factor for mild cognitive impairment or Alzheimer’s disease in 30 US Alzheimer’s disease centers. J Alzheimers Dis31, 265–275.
30.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R, American Psychiatric Association, Washington, DC.
31.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
32.
McKeithIG, GalaskoD, KosakaK, PerryEK, DicksonDW, HansenLA, SalmonDP, LoweJ, MirraSS, ByrneEJ, LennoxG, QuinnNP, EdwardsonJA, IncePG, BergeronC, BurnsA, MillerBL, LovestoneS, CollertonD, JansenEN, BallardC, de VosRA, WilcockGK, JellingerKA, PerryRH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology47, 1113–1124.
33.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, American Psychiatric Association, Washington DC.
BhallaRK, ButtersMA, MulsantBH, BegleyAE, ZmudaMD, SchoderbekB, PollockBG, ReynoldsCF, BeckerJT (2006) Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry14, 419–427.
44.
BhallaRK, ButtersMA, BeckerJT, HouckPR, SnitzBE, LopezOL, AizensteinHJ, RainaKD, DeKoskyST, ReynoldsCF (2009) Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry17, 308–316.
45.
KöhlerS, ThomasAJ, BarnettNA, O’BrienJT (2010) The pattern and course of cognitive impairment in late-life depression. Psychol Med40, 591–602.
46.
RushingNC, Sachs-EricssonN, SteffensDC (2014) Neuropsychological indicators of preclinical Alzheimer’s disease among depressed older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn21, 99–128.
47.
MorimotoSS, KanellopoulosD, ManningKJ, AlexopoulosGS (2015) Diagnosis and treatment of depression and cognitive impairment in late life. Ann N Y Acad Sci1345, 36–46.
DinizBS, ButtersMA, AlbertSM, DewMA, ReynoldsCF (2013) Late-life depression and risk of vascular dementia and Alzheimer’s disease: Systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry202, 329–335.
50.
GedaYE, KnopmanDS, MrazekDA, JichaGA, SmithGE, NegashS, BoeveBF, IvnikRJ, PetersenRC, PankratzVS, RoccaWA (2006) Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: A prospective cohort study. Arch Neurol63, 435–440.
51.
BarnesDE, AlexopoulosGS, LopezOL, WilliamsonJD, YaffeK (2006) Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the Cardiovascular Health Study. Arch Gen Psychiatry63, 273–279.
52.
GedaYE, RobertsRO, MielkeMM, KnopmanDS, ChristiansonTJ, PankratzVS, BoeveBF, SochorO, TangalosEG, PetersenRC, RoccaWA (2014) Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. Am J Psychiatry171, 572–581.
